AliveCor QT Service vs Us2.ca
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
These tools are adjacent in the cardiology AI space but serve distinct diagnostic purposes. AliveCor QT Service focuses on analyzing ECGs for QT/QTc interval measurements to assess cardiac safety and inform medication decisions. In contrast, Us2.ca automates the analysis of echocardiograms to provide comprehensive structural and functional cardiac reports and detect various heart diseases.
Choose AliveCor QT Service if…
Choose AliveCor QT Service if your primary need is rapid, accurate, and instant measurement of QT and QTc intervals from AliveCor 6-Lead ECGs. This tool is ideal for healthcare professionals who need to quickly assess cardiac safety, especially when making critical medication prescribing decisions where drug-induced QT prolongation is a concern.
View AliveCor QT Service →Choose Us2.ca if…
Choose Us2.ca if you require fully automated and comprehensive analysis of echocardiograms to enhance diagnostic accuracy and workflow efficiency. This platform is best suited for practices needing to generate detailed, structured cardiac reports with AI-powered disease detection across a wide range of structural and functional parameters.
View Us2.ca →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AliveCor QT Service | Us2.ca |
|---|---|---|
| Pricing | Varies by product and service, with subscription options available. | Contact for pricing |
| Deployment | Mobile app, cloud-based platform, EHR integration. | Cloud, On-premise |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | 1 AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AliveCor QT Service | Us2.ca |
|---|---|---|
| Name | AliveCor QT Service | Us2.ca |
| Company | AliveCor | Eko.Ai Pte Ltd. D/B/A Us2.Ai |
| Description | A cloud-based Software as a Medical Device (SaMD) that provides instant, accurate QT and QTc interval measurements from AliveCor 6-Lead ECGs, enabling healthcare professionals to assess cardiac safety and inform medication prescribing decisions. | Us2.ai is an FDA-cleared and CE-marked AI platform that fully automates echocardiography analysis, delivering comprehensive, structured cardiac reports in seconds to enhance diagnostic accuracy and workflow efficiency. |
| Primary Function | Instant, accurate QT and QTc interval measurements from AliveCor 6-Lead ECGs. | Fully automated echocardiography analysis and structured cardiac reports. |
| Key Features | Cloud-based Software as a Medical Device (SaMD), Measures QT and QTc intervals (Bazett's and Fridericia's formulas), Analyzes ECGs from AliveCor 6-Lead ambulatory ECG devices (e.g., KardiaMobile 6L), Prescription (Rx) use only, for qualified healthcare professionals, Utilizes AI and deep neural networks for ECG analysis, Provides instant QT measurements (as InstantQT), Integrates with KardiaStation app and KardiaPro portal, API available for integration with EHR, SDK, CRM, EDC, and PSP platforms | Fully automated echocardiography analysis (zero clicks), Real-time processing and structured report generation, AI-powered disease detection (e.g., Cardiac Amyloidosis, Heart Failure, Aortic Stenosis, Pulmonary Hypertension), Integration with ultrasound devices, PACS, CVIS, and EMR, Guideline-based measurements and disease indication conclusions, Explainable AI with editable annotations and visual overlays, Comprehensive cardiac structural and functional parameters (2D, Doppler, M-mode, strain imaging), Cloud and on-premise deployment options |
Videos
Demos, reviews, and walkthroughs featuring AliveCor QT Service and Us2.ca.
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
AliveCor QT Service analyzes 6-Lead ECGs from AliveCor ambulatory ECG devices to measure QT and QTc intervals. Us2.ai fully automates the analysis of echocardiography images to generate comprehensive cardiac reports.
AliveCor QT Service provides instant QT and QTc interval measurements (as InstantQT) to assess cardiac safety and inform medication prescribing decisions, particularly for QT-prolonging medications. Us2.ai offers comprehensive cardiac structural and functional parameters, including AI-powered disease detection for conditions such as Cardiac Amyloidosis, Heart Failure, Aortic Stenosis, and Pulmonary Hypertension.
AliveCor QT Service integrates with the KardiaStation app and KardiaPro portal, and offers an API for integration with EHR, SDK, CRM, EDC, and PSP platforms. Us2.ai integrates with ultrasound devices, PACS, CVIS, and EMR systems, and offers both cloud and on-premise deployment options.
Both AliveCor QT Service and Us2.ai are FDA-cleared. Additionally, Us2.ai is also CE-marked.
AliveCor QT Service is for prescription (Rx) use only, intended for qualified healthcare professionals. The provided information for Us2.ai indicates it is an AI platform that enhances diagnostic accuracy and workflow efficiency, without explicitly stating 'prescription use only'.
More Comparisons
More matchups featuring AliveCor QT Service or Us2.ca
Backers
Who funded each tool's parent company.